论文部分内容阅读
目的:探讨单独使用瑞芬太尼为经皮肝癌射频消融手术提供镇静麻醉的可行性和安全性。方法:抽取2013年10月至2014年8月在我院行经皮肝癌射频消融术的79例患者作为研究对象,单独使用瑞芬太尼为患者进行镇静镇痛麻醉,观察患者手术过程中的生命体征、血氧饱和度变化和不良反应,记录手术后患者的意识恢复时间并以问卷形式了解患者对手术的满意度。结果:79例患者均顺利完成手术,手术过程中生命体征和血氧饱和度正常,未发生不良反应,手术结束停止用药后患者意识恢复时间为12±3分钟,患者对手术的满意度为98.73%。结论:经皮肝癌射频消融手术患者单独使用瑞芬太尼进行镇静镇痛麻醉的不良反应少,苏醒快,手术过程中患者生命体征平稳,安全性高,具有可行性。
Objective: To investigate the feasibility and safety of remifentanil alone in providing sedative anesthesia for radiofrequency ablation of percutaneous liver cancer. Methods: Totally 79 patients with percutaneous liver cancer radiofrequency ablation in our hospital from October 2013 to August 2014 were enrolled in this study. Remifentanil alone was used for sedation and analgesia anesthesia to observe the life of the patients during operation Signs, changes in oxygen saturation and adverse reactions, record the recovery time of patients after surgery and questionnaire to understand the patient’s satisfaction with surgery. Results: All the 79 patients completed the operation successfully. The vital signs and oxygen saturation during the operation were normal without any adverse reactions. The patients ’recovery time after stopping the operation was 12 ± 3 minutes and the patients’ satisfaction with the operation was 98.73 %. Conclusion: The patients with percutaneous liver cancer radiofrequency ablation alone remifentanil sedative and analgesic anesthesia less adverse reactions, rapid recovery, the patients during surgery vital signs stable, safe and feasible.